KNSA compared with ANIP: revenue, margins and what each company keeps, and the suppliers and customers both name

KNSAKiniksa Pharmaceuticals International, plc

Mkt capRevenueRevenue

ANIPANI Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

KNSAKiniksa Pharmaceuticals International, plc

ANIPANI Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only KNSA 10

REGNRegeneronsupplier

BIIBBiogen MAsupplier

—Samsungunlistedsupplier

—Beth Israel Deaconess Medical Center, Inc. ("BIDMC")unlistedsupplier

6 more · KNSA chain ›

Shared 0

No shared counterparties.

Only ANIP 33

—Three customersunlistedcustomer

—One domestic supplierunlistedsupplier

WMTWalmartcustomer

CVS

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

CVS

customer

29 more · ANIP chain ›

KNSAKiniksa Pharmaceuticals International, plc

93.10▲+2.53%· post 93.75

Mkt cap$7.1BRevenue$286MQ3 FY26Revenue$678MFY25

ANIPANI Pharmaceuticals Inc

71.77▲+1.55%· post 71.77

ClosedNov 3 '26

Mkt cap$1.7BRevenue$266MQ2 FY26Revenue$883MFY25

Compare

ClosedNov 3 '26

KNSAKiniksa Pharmaceuticals International, plc

ANIPANI Pharmaceuticals Inc

93.10▲+2.53%post 93.75

Price

71.77▲+1.55%post 71.77

$7.1B

Mkt cap

$1.7B

Q3 FY26$286M

Revenue

$266MQ2 FY26

FY25$678M

Revenue

$883MFY25

KNSA93.10▲+2.53%vsANIP71.77▲+1.55%ClosedNov 3 '26